Home/Filings/4/0000875045-25-000051
4//SEC Filing

Grogan Jane 4

Accession 0000875045-25-000051

CIK 0000875045other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 4:12 PM ET

Size

8.2 KB

Accession

0000875045-25-000051

Insider Transaction Report

Form 4
Period: 2025-10-31
Grogan Jane
Head of Research
Transactions
  • Tax Payment

    Common Stock

    2025-10-31$154.27/sh337$51,9891,791 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-10-31695695 total
    Exercise: $0.00Exp: 2026-11-01Common Stock (695 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-31+6952,128 total
Footnotes (1)
  • [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of November 1, 2023.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001995547

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:12 PM ET
Size
8.2 KB